FDA Advisory Panel Favors Extended Use of Xeljanz by Certain Ulcerative Colitis Patients
News
An advisory arm of the U.S. Food and Drug Administration (FDA) gave two positive recommendations to Pfizer’s supplemental New Drug Application, seeking FDA approval for extended use of Xeljanz (tofacitinib) by certain adult ... Read more